The ION-Ghent guidelines for the management of immune related adverse events (irAE's)
- Author
- Vibeke Kruse (UGent) , Max Schreuer (UGent) , Karim Vermaelen (UGent) , Piet Ost (UGent) , Tessa Kerre (UGent) , Barbara De Moerloose (UGent) and Lieve Brochez (UGent)
- Organization
Downloads
-
(...).pdf
- full text
- |
- UGent only
- |
- |
- 1.61 MB
Citation
Please use this url to cite or link to this publication: http://hdl.handle.net/1854/LU-8554892
- Chicago
- Kruse, Vibeke, Max Schreuer, Karim Vermaelen, Piet Ost, Tessa Kerre, Barbara De Moerloose, and Lieve Brochez. 2017. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (irAE’s).” Belgian Journal of Medical Oncology 11 (6): 265–275.
- APA
- Kruse, V., Schreuer, M., Vermaelen, K., Ost, P., Kerre, T., De Moerloose, B., & Brochez, L. (2017). The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY, 11(6), 265–275.
- Vancouver
- 1.Kruse V, Schreuer M, Vermaelen K, Ost P, Kerre T, De Moerloose B, et al. The ION-Ghent guidelines for the management of immune related adverse events (irAE’s). BELGIAN JOURNAL OF MEDICAL ONCOLOGY. 2017;11(6):265–75.
- MLA
- Kruse, Vibeke et al. “The ION-Ghent Guidelines for the Management of Immune Related Adverse Events (irAE’s).” BELGIAN JOURNAL OF MEDICAL ONCOLOGY 11.6 (2017): 265–275. Print.
@article{8554892,
author = {Kruse, Vibeke and Schreuer, Max and Vermaelen, Karim and Ost, Piet and Kerre, Tessa and De Moerloose, Barbara and Brochez, Lieve},
issn = {1784-7141},
journal = {BELGIAN JOURNAL OF MEDICAL ONCOLOGY},
language = {eng},
number = {6},
pages = {265--275},
title = {The ION-Ghent guidelines for the management of immune related adverse events (irAE's)},
volume = {11},
year = {2017},
}